Developer of novel therapies designed for the treatment of respiratory diseases. The company engages in the modulation of receptors for advanced glycation end-products that are crucial to targeting ch...

Healthcare
Melbourne, Australia
Founded 2020
8 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$22.9M
Last Round
N/A

Get the full picture

Create a free account to unlock RAGE Biotech's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required